MedTrace Logo

Cognitive Remediation Therapy (CRT) in Adolescents With EOS

NCT01701609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-08-13

No results posted yet for this study

Summary

Cognitive Remediation Therapy (CRT) can enhance cognitive performance in schizophrenia improving functional outcome. But most of the studies have involved participants who are in average in their mid 30s, and little is known about the efficacy of CRT in adolescents with early-onset schizophrenia (EOS). The aim of this study is to investigate efficacy of CRT in improving cognitive performance and functional outcome in adolescents with EOS. We expect to find that CRT improves cognitive and functional outcomes in adolescents with schizophrenia.

Conditions

Interventions

BEHAVIORAL

Cognitive Remediation Therapy

Sponsors & Collaborators

  • Instituto de Salud Carlos III

    collaborator OTHER_GOV

  • Centro de Investigación Biomédica en Red de Salud Mental

    collaborator NETWORK

  • Hospital Clinic of Barcelona

    lead OTHER

Principal Investigators

  • Olga Puig, PhD · Hospital Clinic of Barcelona

  • Rafael Penadés, PhD · Hospital Clinic of Barcelona

  • Josefina Castro-Fornieles, MD · Hospital Clinic of Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-12-31
Completion
2013-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01701609 on ClinicalTrials.gov